Objects
Sanson-Fisher, Rob, Brand, Matthew, Shakeshaft, Anthony, Haber, Paul, Day, Carolyn, Conigrave, Katherine, Mattick, Richard, Lintzeris, Nicholas, Teesson, Maree. Wiley-Blackwell Publishing; 2010. Forming a national multicentre collaboration to conduct clinical trials: increasing high-quality research in the drug and alcohol field.
McNamara, Kelly A., Murnion, Bridin, Fotheringham, Penelope, Terplan, Mishka, Lintzeris, Nicholas, Oei, Ju Lee, Bond, Diana M., Nassar, Natasha, Black, Kirsten I.. BMJ Group; 2024. Interconnections between unintended pregnancy, alcohol and other drug use, and pregnancy, birth, infant, childhood and socioeconomic outcomes: a scoping review.
Deacon, Rachel M., Mammen, Kristie, Holmes, Jennifer, Dunlop, Adrian, Bruno, Raimondo, Mills, Llewellyn, Graham, Robert, Lintzeris, Nicholas. Wiley-Blackwell; 2020. Assessing the validity of the Australian treatment outcomes profile for telephone administration in drug health treatment populations.
Holliday, Simon, Magin, Parker, Dunbabin, Janet, Oldmeadow, Christopher, Henry, Julie-Marie, Lintzeris, Nicholas, Attia, John, Goode, Susan, Dunlop, Adrian. Wiley-Blackwell Publishing; 2013. An evaluation of the prescription of opioids for chronic nonmalignant pain by Australian general practitioners.
Holliday, Simon, Magin, Parker, Oldmeadow, Christopher, Attia, John, Dunbabin, Janet, Henry, Julie-Marie, Lintzeris, Nicholas, Goode, Susan, Dunlop, Adrian. Wiley-Blackwell Publishing; 2013. An examination of the influences on New South Wales general practitioners regarding the provision of opioid substitution therapy.
Barnett, Anthony, Savic, Michael, Lintzeris, Nicholas, Bathish, Ramez, Arunogiri, Shalini, Dunlop, Adrian J., Haber, Paul, Graham, Robert, Hayes, Vicky, Lubman, Dan I.. Elsevier; 2021. Tracing the affordances of long-acting injectable depot buprenorphine: A qualitative study of patients’ experiences in Australia.
Ryan, Anni, Holmes, Jennifer, Hunt, Vi, Dunlop, Adrian, Mammen, Kristie, Holland, Rohan, Sutton, Yvonne, Sindhusake, Doungkamol, Rivas, Gonzalo, Lintzeris, Nicholas. Wiley-Blackwell Publishing; 2014. Validation and implementation of the Australian Treatment Outcomes Profile in specialist drug and alcohol settings.
Acheson, Liam S., Clay, Simon, Ezard, Nadine, Siefried, Krista J., McKetin, Rebecca, Lintzeris, Nicholas, Dunlop, Adrian, Brett, Jonathan, Christmass, Michael, Rodgers, Craig, Shoptaw, Steve, Farrell, Michael. Elsevier; 2024. Participant experiences in a pilot study for methamphetamine withdrawal treatment: Implications for retention.
Larance, Briony, Bruno, Raimondo, Mattick, Richard P., Lintzeris, Nicholas, Degenhardt, Louise, Black, Emma, Brown, Amanda, Nielsen, Suzanne, Dunlop, Adrian, Holland, Rohan, Cohen, Milton. Elsevier; 2016. Development of a brief tool for monitoring aberrant behaviours among patients receiving long-term opioid therapy: the Opioid-Related Behaviours In Treatment (ORBIT) scale.
Nielsen, Suzanne, Picco, Louisa, Farrell, Michael, Lintzeris, Nicholas, Le Foll, Bernard, Murnion, Bridin, Winters, Bryony, Matheson, Justin, Graham, Myfanwy, Campbell, Gabrielle, Parvaresh, Laila, Khor, Kok-Eng, Betz-Stablein, Brigid. Nature Publishing Group; 2022. Opioid-sparing effect of cannabinoids for analgesia: an updated systematic review and meta-analysis of preclinical and clinical studies.
Farrell, Michael, Shahbazi, Jeyran, Byrne, Marianne, Grebely, Jason, Lintzeris, Nicholas, Chambers, Mark, Larance, Briony, Ali, Robert, Nielsen, Suzanne, Dunlop, Adrian, Dore, Gregory J., McDonough, Michael, Montebello, Mark, Nicholas, Thomas, Weiss, Rob, Rodgers, Craig, Cook, Jon, Degenhardt, Louisa. Elsevier; 2022. Outcomes of a single-arm implementation trial of extended-release subcutaneous buprenorphine depot injections in people with opioid dependence.
Ezard, Nadine, Clifford, Brendan, Dunlop, Adrian, Bruno, Raimondo, Carr, Andrew, Liu, Zhixin, Siefried, Krista J., Lintzeris, Nicholas. B M J Group; 2021. Safety and tolerability of oral lisdexamfetamine in adults with methamphetamine dependence: a phase-2 dose-escalation study.
Allsop, David J., Copeland, Jan, Booth, Jessica, McGregor, Iain S., Lintzeris, Nicholas, Dunlop, Adrian J., Montebello, Mark, Sadler, Craig, Rivas, Gonzalo R., Holland, Rohan M., Muhleisen, Peter, Norberg, Melissa M.. American Medical Association; 2014. Nabiximols as an agonist replacement therapy during cannabis withdrawal: a randomized clinical trial.
Nielsen, Suzanne, Murnion, Bridin, Dunlop, Adrian, Degenhardt, Louisa, Demirkol, Apo, Muhleisen, Peter, Lintzeris, Nicholas. Wiley-Blackwell; 2015. Comparing treatment-seeking codeine users and strong opioid users: findings from a novel case series.
Lintzeris, Nicholas, Mills, Llewellyn, Kevin, Richard, Bhardwaj, Anjali, Dunlop, Adrian, Copeland, Jan, Mcgregor, Iain, Bruno, Raimondo, Kirby, Adrienne, Montebello, Mark, Hall, Michelle, Jefferies, Meryem. Elsevier; 2020. Cannabis use in patients 3 months after ceasing nabiximols for the treatment of cannabis dependence: results from a placebo-controlled randomised trial.
McCartney, Danielle, Isik, Ashling D., Rooney, Kieron, Arnold, Jonathon C., Bartlett, Delwyn J., Murnion, Bridin, Richards, Elisha, Arkell, Thomas R., Lintzeris, Nicholas, McGregor, Iain S.. Wiley-Blackwell; 2020. The effect of daily aerobic cycling exercise on sleep quality during inpatient cannabis withdrawal: A randomised controlled trial.
Nielsen, Suzanne, Bruno, Raimondo, Murnion, Bridin, Dunlop, Adrian, Degenhardt, Louisa, Demirkol, Apo, Muhleisen, Peter, Lintzeris, Nicholas. Wiley-Blackwell; 2016. Treating codeine dependence with buprenorphine: dose requirements and induction outcomes from a retrospective case series in New South Wales, Australia.
Farrell, Michael, Shahbazi, Jeyran, Nielsen, Suzanne, Dunlop, Adrian, Dore, Gregory J., McDonough, Michael, Montebello, Mark, Weiss, Rob, Rodgers, Craig, Cook, Jon, Degenhardt, Louisa, Chambers, Mark, Byrne, Marianne, Gholami, Jaleh, Zahra, Emma, Grebely, Jason, Lintzeris, Nicholas, Larance, Briony, Ali, Robert. Elsevier; 2024. 96-week retention in treatment with extended-release subcutaneous buprenorphine depot injections among people with opioid dependence: Extended follow-up after a single-arm trial.
Stirling, Robert, Hudson, Suzie, Ross, Joanne, Deans, Emily, Tibbetts, Joel, Day, Carolyn, Deacon, Rachel, Dunlop, Adrian, Lintzeris, Nicholas. Wiley-Blackwell; 2024. Understanding the research capacity of alcohol and other drugs services in New South Wales, Australia.
Mammen, Kristie, Mills, Llewellyn, Deacon, Rachel M., Bruno, Raimondo, Dunlop, Adrian, Holmes, Jennifer, Luksza, Jennifer, Shakeshaft, Anthony, Farrell, Michael, Lintzeris, Nicholas. Wiley-Blackwell; 2022. Determining clinical cutoff scores for the Australian Treatment Outcomes Profile psychological health, physical health and quality of life questions.
Montebello, Mark, Jefferies, Meryem, Lintzeris, Nicholas, Agonist Replacement For Cannabis Dependence Study Group (ARC-D),, Mills, Llewellyn, Bruno, Raimondo, Copeland, Jan, McGregor, Iain, Rivas, Consuelo, Jackson, Melissa A., Silsbury, Catherine, Dunlop, Adrian. Elsevier; 2022. Mood, sleep and pain comorbidity outcomes in cannabis dependent patients: Findings from a nabiximols versus placebo randomised controlled trial.
Kevin, Richard C., Allsop, David J., Lintzeris, Nicholas, Dunlop, Adrian J., Booth, Jessica, McGregor, Iain S.. Springer; 2017. Urinary cannabinoid levels during nabiximols (Sativex®)-medicated inpatient cannabis withdrawal.
Dunlop, Adrian, Lokuge, Buddhima, Masters, Debbie, Sequeira, Marcia, Saul, Peter, Dunlop, Grace, Ryan, John, Hall, Michelle, Ezard, Nadine, Haber, Paul, Lintzeris, Nicholas, Maher, Lisa. BioMed Central (BMC); 2020. Challenges in maintaining treatment services for people who use drugs during the COVID-19 pandemic.
Nielsen, Suzanne, Larance, Briony, Lintzeris, Nicholas, Black, Emma, Bruno, Raimondo, Murnion, Bridin, Dunlop, Adrian, Degenhardt, Louisa. Wiley-Blackwell Publishing; 2013. Correlates of pain in an in-treatment sample of opioid-dependent people.
Lintzeris, Nicholas, Bhardwaj, Anjali, Chan, Therese, Kirby, Adrienne, Hall, Michelle, Jefferies, Meryem, Luksza, Jennifer, Shanahan, Marian, Kevin, Richard, Allsop, David, Mills, Llewellyn, Dunlop, Adrian, Copeland, Jan, McGregor, Iain, Bruno, Raimondo, Gugusheff, Jessica, Phung, Nghi, Montebello, Mark. American Medical Association; 2019. Nabiximols for the treatment of cannabis dependence: a randomized clinical trial.
Dunlop, Adrian J., Dunlop, AJ, Brown, AL, Oldmeadow, C, Attia, J, Harris, A, Ghijben, P, Sadler, C, Attia, J, Bell, J, Bell, J, Lintzeris, N, Brown, Amanda L., Hinman, Jennifer, Jackson, Melissa, Bell, James, Lintzeris, Nicholas, Oldmeadow, Christopher, Harris, Anthony, Gill, Anthony, Sadler, Craig, Ribbons, Karen, Attia, John, Barker, Daniel, Ghijben, Peter. Elsevier; 2017. Effectiveness and cost-effectiveness of unsupervised buprenorphine-naloxone for the treatment of heroin dependence in a randomized waitlist controlled trial.
Lintzeris, Nicholas, Dunlop, Adrian J., Peterson, Stefan, Tiberg, Fredrik, Haber, Paul S., Lubman, Dan I., Graham, Robert, Hutchinson, Sarah, Arunogiri, Shalini, Hayes, Victoria, Hjelmström, Peter, Svedberg, Agneta. AMER MEDICAL ASSOC; 2021. Patient-Reported outcomes of treatment of opioid dependence with weekly and monthly subcutaneous depot vs daily sublingual buprenorphine: a randomized clinical trial.
Mills, Llewellyn, Lintzeris, Nicholas, Bruno, Raimondo, Montebello, Mark, Dunlop, Adrian, Deacon, Rachel M., Copeland, Jan, Jefferies, Meryem, Rivas, Consuelo, Mammen, Kristie. Wiley-Blackwell; 2020. Validation of the Australian Treatment Outcomes Profile for use in clients with cannabis dependence.
Mills, Llewellyn, Dunlop, Adrian, Montebello, Mark, Copeland, Jan, Bruno, Raimondo, Jefferies, Meryem, Mcgregor, Iain, Lintzeris, Nicholas. BioMed Central (BMC); 2022. Correlates of treatment engagement and client outcomes: results of a randomised controlled trial of nabiximols for the treatment of cannabis use disorder.
Murnion, Bridin Patricia, Rivas, Consuelo, Demirkol, Apo, Hayes, Vicky, Lintzeris, Nicholas, Nielsen, Suzanne. Oxford University Press; 2020. Acute experimental pain responses in methadone- and buprenorphine/naloxone-maintained patients administered additional opioid or gabapentin: a double-blind crossover pilot study.
Black, Emma, Mammen, Kristie, Shakeshaft, Anthony, Siefried, Krista J., Farrell, Michael, Holmes, Jennifer, Lintzeris, Nicholas, Deacon, Rachel M., Ezard, Nadine, Mills, Llewellyn, Dunlop, Adrian J., Montebello, Mark, Reid, David, Childs, Steven, Bruno, Raimondo. Wiley-Blackwell; 2023. Health and Social Characteristics of Clients Reporting Amphetamine Type Substance Use at Entry to Public Alcohol and Other Drug Services in New South Wales, Australia, 2016–2019.
Nielsen, Suzanne, Lintzeris, Nicholas, Dunlop, Adrian, Demirkol, Apo, Silsbury, Catherine, Phung, Nghi, Houseman, Jennie, Larance, Briony, Murnion, Bridin, Degenhardt, Louisa, Bruno, Raimondo, Haber, Paul, Johnson, Jennifer, Hardy, Mark, Ling, Stephen, Saddler, Craig. Wiley-Blackwell; 2018. Understanding an emerging treatment population: Protocol for and baseline characteristics of a prospective cohort of people receiving treatment for pharmaceutical opioid dependence.
Black, Emma, Bruno, Raimondo, Childs, Steven, Reid, David, Holmes, Jennifer, Lintzeris, Nicholas, Mammen, Kristie, Mills, Llewellyn, Siefried, Krista J., Deacon, Rachel M., Shakeshaft, Anthony, Dunlop, Adrian J., Ezard, Nadine, Montebello, Mark. John Wiley & Sons; 2023. Substance use, socio-demographic characteristics, and self-rated health of people seeking alcohol and other drug treatment in New South Wales: baseline findings from a cohort study.
Acheson, Liam S., Ezard, Nadine, Shoptaw, Steve, Siefried, Krista J., Lintzeris, Nicholas, Dunlop, Adrian, Brett, Jonathan, Rodgers, Craig, Gill, Anthony, Christmass, Michael, McKetin, Rebecca, Farrell, Michael. Elsevier; 2022. Lisdexamfetamine for the treatment of acute methamphetamine withdrawal: A pilot feasibility and safety trial.
Frost, Michael, Bailey, Genie L., Oosman, Sonia, Kim, Sonnie, Tiberg, Fredrik, Lintzeris, Nicholas, Strang, John, Dunlop, Adrian, Nunes, Edward V., Jansen, Jakob Billeskov, Frey, Lars Chemnitz, Weber, Bernd, Haber, Pauk. Wiley-Blackwell; 2019. Long-term safety of a weekly and monthly subcutaneous buprenorphine depot (CAM2038) in the treatment of adult out-patients with opioid use disorder.
Dunlop, Adrian J., White, Bethany, Attia, John, Oldmeadow, Christopher, Howard, Mark V., Murrell, Terry, Haber, Paul Steen, Lintzeris, Nicholas, Roberts, Jillian, Cretikos, Michelle, Attalla, Dena, Ling, Rod, Searles, Andrew, Mackson, Judith, Doyle, Michael F., McEntyre, Elizabeth. Wiley-Blackwell; 2021. Treatment of opioid dependence with depot buprenorphine (CAM2038) in custodial settings.
Deacon, Rachel M., Mammen, Kristie, Bruno, Raimondo, Mills, Llewellyn, Dunlop, Adrian, Holmes, Jennifer, Jefferies, Meryem, Hall, Michelle, Shakeshaft, Anthony, Farrell, Michael, Graham, Robert, Lintzeris, Nicholas. Wiley-Blackwell; 2021. Assessing the concurrent validity, inter-rater reliability and test-re-test reliability of the Australian Treatment Outcomes Profile (ATOP) in alcohol and opioid treatment populations.
Settumba, Stella, Shahbazi, Jeyran, Blazey, Alison, Weiss, Robert, Dunlop, Adrian, McDonough, Michael, Cook, Jon, Farrell, Michael, Byrne, Marianne, Degenhardt, Louisa, Grebely, Jason, Larance, Briony, Nielsen, Suzanne, Lintzeris, Nicholas, Ali, Robert, Rodgers, Craig. Wiley-Blackwell; 2025. Provider costs of treating opioid dependence with extended-release buprenorphine in Australia.